The persistence of very low correlations between NIH research funding and disease burdens

Objectives: The degree to which the allocation of disease-specific research funding by the NIH is proportional to disease burden is an important question. This study examined the historical relationship between NIH funding allocation and disease burden for a variety of medical conditions. Study desi...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashley J.R. Carter, Milena Gevorkian
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Public Health in Practice
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666535224001174
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560478484004864
author Ashley J.R. Carter
Milena Gevorkian
author_facet Ashley J.R. Carter
Milena Gevorkian
author_sort Ashley J.R. Carter
collection DOAJ
description Objectives: The degree to which the allocation of disease-specific research funding by the NIH is proportional to disease burden is an important question. This study examined the historical relationship between NIH funding allocation and disease burden for a variety of medical conditions. Study design: Coefficients of relatedness for the linear relationships between funding and disease burden for 27 medical conditions over a period exceeding twenty years were calculated. Methods: Publicly available data from 2009 to 2019, and previously published data from 1994 to 2004, was obtained to compare disease-specific research funding from the NIH to burden of disease values (mortality, prevalence, incidence, DALYs, and YLLs) for 27 diseases. Results: We identified very weak and declining correlations (e.g., R2 < 0.03) between funding and the five measures of burden for the 27 diseases. The weak relationships persist even when HIV/AIDS is omitted (e.g., R2 < 0.1). A recent decline in the overall strengths of the funding burden relationships is attributable to novel investment in Alzheimer's disease research. Conclusions: The weak correlations reveal long-standing inefficiencies in the NIH disease funding allocation process. The recent increased and focused funding for Alzheimer's disease may not be justified by an objective analysis which considers disease burdens. Increased efficiency of medical research may be realized by improving the poor match between disease burden and funding allocation.
format Article
id doaj-art-5291ac48de944290812b9d5e289350f3
institution Kabale University
issn 2666-5352
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Public Health in Practice
spelling doaj-art-5291ac48de944290812b9d5e289350f32025-01-04T04:57:12ZengElsevierPublic Health in Practice2666-53522025-06-019100580The persistence of very low correlations between NIH research funding and disease burdensAshley J.R. Carter0Milena Gevorkian1Corresponding author.; California State University Long Beach, Long Beach, CA, USACalifornia State University Long Beach, Long Beach, CA, USAObjectives: The degree to which the allocation of disease-specific research funding by the NIH is proportional to disease burden is an important question. This study examined the historical relationship between NIH funding allocation and disease burden for a variety of medical conditions. Study design: Coefficients of relatedness for the linear relationships between funding and disease burden for 27 medical conditions over a period exceeding twenty years were calculated. Methods: Publicly available data from 2009 to 2019, and previously published data from 1994 to 2004, was obtained to compare disease-specific research funding from the NIH to burden of disease values (mortality, prevalence, incidence, DALYs, and YLLs) for 27 diseases. Results: We identified very weak and declining correlations (e.g., R2 < 0.03) between funding and the five measures of burden for the 27 diseases. The weak relationships persist even when HIV/AIDS is omitted (e.g., R2 < 0.1). A recent decline in the overall strengths of the funding burden relationships is attributable to novel investment in Alzheimer's disease research. Conclusions: The weak correlations reveal long-standing inefficiencies in the NIH disease funding allocation process. The recent increased and focused funding for Alzheimer's disease may not be justified by an objective analysis which considers disease burdens. Increased efficiency of medical research may be realized by improving the poor match between disease burden and funding allocation.http://www.sciencedirect.com/science/article/pii/S2666535224001174Research fundingDisease burdenDisability adjusted life yearsYears of life lost
spellingShingle Ashley J.R. Carter
Milena Gevorkian
The persistence of very low correlations between NIH research funding and disease burdens
Public Health in Practice
Research funding
Disease burden
Disability adjusted life years
Years of life lost
title The persistence of very low correlations between NIH research funding and disease burdens
title_full The persistence of very low correlations between NIH research funding and disease burdens
title_fullStr The persistence of very low correlations between NIH research funding and disease burdens
title_full_unstemmed The persistence of very low correlations between NIH research funding and disease burdens
title_short The persistence of very low correlations between NIH research funding and disease burdens
title_sort persistence of very low correlations between nih research funding and disease burdens
topic Research funding
Disease burden
Disability adjusted life years
Years of life lost
url http://www.sciencedirect.com/science/article/pii/S2666535224001174
work_keys_str_mv AT ashleyjrcarter thepersistenceofverylowcorrelationsbetweennihresearchfundinganddiseaseburdens
AT milenagevorkian thepersistenceofverylowcorrelationsbetweennihresearchfundinganddiseaseburdens
AT ashleyjrcarter persistenceofverylowcorrelationsbetweennihresearchfundinganddiseaseburdens
AT milenagevorkian persistenceofverylowcorrelationsbetweennihresearchfundinganddiseaseburdens